drugset / Trial / NCT00124150

Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH)

NCT00124150

Phase 3 Completed 327 enrolled Chinese University of Hong Kong
RandomizedParallel-groupTriple-blindPrevention

Summary

The IMASH trial is a simple, randomized, double-blinded, placebo-controlled, multi-center trial to answer the question: "Does intravenous magnesium sulfate improve clinical outcome after aneurysmal subarachnoid hemorrhage?"

Timeline

Start
2002-06
Primary completion
2008-12
Completion
2009-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 80 mg Intravenous
Subject Magnesium Sulfate Other / unclassified 80 mmol Intravenous